Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Brennan Daniel J., Chief Financial Officer. Director active across 4 companies, notably Nuance Communications, Inc.. Cumulatively, 34 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €724k. History available since 1 January 2022. The latest transaction was filed on 18 February 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Daniel J. Brennan serves as the Chief Financial Officer at Boston Scientific Corp and Nuance Communications, Inc. He is responsible for financial management and strategy for both companies. His expertise is crucial in ensuring the financial strength and growth of these firms.